Hepatitis C viral clearance and antibody reactivity patterns in persons with haemophilia and other congenital bleeding disorders

Haemophilia

Volumn 7, Issue 6, 2001, Pages 568-574

  Messick, K ^a   Sanders, J C ^a   Goedert, J J ^b   Eyster, M E ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Haemophilia; HCV RNA; Hepatitis C; HIV coinfection; RIBA patterns; Viral clearance

Indexed keywords

BLOOD CLOTTING FACTOR; DNA; EPITOPE; HEPATITIS C ANTIBODY; VIRUS RNA; CORE PROTEIN; CORE PROTEIN P22, HEPATITIS C VIRUS; HEPATITIS C ANTIGEN; NUCLEOCAPSID PROTEIN, HEPATITIS C VIRUS;

ADOLESCENT; ADULT; AGE; ARTICLE; BLEEDING DISORDER; BLOOD TRANSFUSION; CHILD; CHRONIC HEPATITIS; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DNA DETERMINATION; EXPOSURE; HEMOPHILIA; HEPATITIS; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOBLOTTING; IMMUNOREACTIVITY; INFANT; INFECTION RISK; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIREMIA; VIRUS DETECTION; VIRUS EXCRETION; AGE DISTRIBUTION; BLOOD; BLOOD CLOTTING DISORDER; GENETICS; GROWTH, DEVELOPMENT AND AGING; HEMOPHILIA A; HEPATITIS C; IMMUNOLOGY; MIDDLE AGED; PRESCHOOL CHILD; PROGNOSIS; VIROLOGY;

ADOLESCENT; ADULT; AGE DISTRIBUTION; BLOOD COAGULATION DISORDERS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; EPITOPES; HEMOPHILIA A; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HIV INFECTIONS; HUMAN; INFANT; MIDDLE AGE; PROGNOSIS; RNA, VIRAL; SUPPORT, NON-U.S. GOV'T; VIRAL CORE PROTEINS; HEPATITIS C ANTIGENS; HUMANS; MIDDLE AGED;

EID: 0035543818     PISSN: 13518216     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2516.2001.00559.x     Document Type: Article

References (26)

1. Non-A non-B hepatitis after transfusion of factor VIII in infrequently treated patients
2. High risk of non-A non-B hepatitis after a first exposure to volunteer or commercial clotting factor concentrates: Effects of prophylactic immune serum globulin
3. Use of several second generation serological assays to determine the true prevalence of hepatitis C infection in haemophiliacs treated with non-virus inactivated VIII and IX concentrates
4. The natural history of chronic hepatitis C in hemophiliacs
5. Abnormal serum transaminase levels in patients with hemophilia A
6. The progression of HCV-associated liver disease in a cohort of haemophilic patients
7. Evidence for persistent hepatitis C virus (HCV) infection in hemophiliacs
8. The kinetics of antibodies against hepatitis C virus may predict viral clearance in exposed hemophiliacs
9. Clinical outcomes after transfusion-associated hepatits C
10. Non-A, non-B hepatitis. Looking back in the second decade
11. The detection, transmission and outcome of hepatitis C virus infection
12. Hepatitis C and hepatocellular carcinoma
13. Pathogenesis, natural history, treatment, and prevention of hepatitis C
14. Natural history of hepatitis C virus infection in multitransfused hemophiliacs; effect of coinfection with human immunodeficiency virus
15. A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia
16. Natural history of human immunodeficiency virus infections in hemophiliacs: Effects of T-cell subsets, platelet counts, and age
17. Decrease in serum hepatitis C viral RNA during alpha-interferon therapy for chronic hepatitis C
18. Increasing hepatitis C virus RNA levels in hemophiliacs: Relationship to human immunodeficiency virus infection and liver disease
19. Chronic hepatitis C virus infections in leukemia survivors: Prevalence, viral load, and severity of liver disease
20. Long-term mortality and morbidity of transfusion-associated non-A, non-B and type C Hepatitis: A National Heart, Lung and Blood Institute collaborative study
21. Hepatitis C virus infected HCV RNA negative patients with bleeding disorders: Relationship to age, HIV, and treatment
22. Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening
23. Full or partial seroreversion in patients infected by hepatitis C virus
24. Persistence of viremia and the importance of long-term follow up after acute hepatitis C infection
25. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C
26. Clinical significance of intrahepatic hepatitis C virus levels in patients with chronic HCV infection